What does Mission Bay Capital invest in?
Mission Bay Capital invests most often at Series A and Seed (59% of the rounds on record), in sectors such as Life Science.

United States · Investor
Last cheque observed Aug 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
VC firmQuietLast fund $26M, Aug 2018
Follow Mission Bay Capital and see its new cheques in your feed. Start following
18 rounds on record
Mostly Series A and Seed: 59% of its rounds
Sole investor in 3 rounds, median $4.5M
Early stage life science venture capital firm.From their own website
Every round we can evidence, newest first18 appearances
1 round
1 round
2 rounds
1 round
4 rounds
4 rounds
1 round
1 round
2 rounds
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
We also hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Who backs their funds
The institutions that put money into its funds, which the firm then invests in companies.Source: the pension's own report, latest Jun 2025.
| Fund | Vintage | Committed |
|---|---|---|
| Mission Bay Capital III | 2018 | $5.0M |
| Mission Bay Capital II | 2015 | $3.9M |
From their own portfolio page (on their website)
AlessatherapeuticsAmbagon-therapeuticsApplaudmedicalAsherbioCelldesignlabsChronotheraCirclepharmaDrenbioEpiodyneGlycomineInvenio-imagingKitMammothMitokinineFFECTOR1Alpine-roadsAvexegenCariboubioFluxionbioGraphwearLogic
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as Mission Bay Capital. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Mission Bay Capital put money into.
Mission Bay Capital invests most often at Series A and Seed (59% of the rounds on record), in sectors such as Life Science.
18 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2019.
Its most recent investments on record: Glycomine (Series B, Aug 2019), Wild Type (Seed, Mar 2018) and Pionyr (Series B, Dec 2017).
The median round it joins is $33M.
Rarely, if at all: none of its 18 investments on record names it as the lead.
Most of the companies it backs are in the United States (100%).
No investments in the last 12 months; the latest was in Aug 2019.
Most often OrbiMed (4 rounds together), Morgenthaler Ventures (3 rounds together) and SR One (3 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it